| NF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription TE Novak, TA Babcock, DH Jho, WS Helton, NJ Espat American Journal of Physiology-Lung Cellular and Molecular Physiology 284 (1 …, 2003 | 586 | 2003 |
| Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases SC Katz, RA Burga, E McCormack, LJ Wang, W Mooring, GR Point, ... Clinical cancer research 21 (14), 3149-3159, 2015 | 445 | 2015 |
| Conventional hemangiopericytoma: modern analysis of outcome NJ Espat, JJ Lewis, D Leung, JM Woodruff, CR Antonescu, J Shia, ... Cancer 95 (8), 1746-1751, 2002 | 280 | 2002 |
| Short-term outcomes with small intestinal submucosa for ventral abdominal hernia WS Helton, PM Fisichella, R Berger, S Horgan, NJ Espat, H Abcarian Archives of surgery 140 (6), 549-562, 2005 | 274 | 2005 |
| Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in … K Turaga, E Levine, R Barone, R Sticca, N Petrelli, L Lambert, G Nash, ... Annals of surgical oncology 21, 1501-1505, 2014 | 245 | 2014 |
| Robotic-assisted minimally invasive transhiatal esophagectomy S Horgan, RA Berger, EF Elli, NJ Espat The American surgeon 69 (7), 624-626, 2003 | 209 | 2003 |
| Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature S Garrean, J Hering, A Saied, WS Helton, NJ Espat The American journal of surgery 195 (4), 508-520, 2008 | 198 | 2008 |
| Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis C Boutros, P Somasundar, S Garrean, A Saied, NJ Espat Surgical oncology 19 (1), e22-e32, 2010 | 176 | 2010 |
| The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair MB Welborn, HSA Oldenburg, PJ Hess, TS Huber, TD Martin, ... Critical Care Medicine 28 (9), 3191-3197, 2000 | 172 | 2000 |
| Efficacy and tolerability of 5-year adjuvant imatinib treatment for patients with resected intermediate-or high-risk primary gastrointestinal stromal tumor: the PERSIST-5 … CP Raut, NJ Espat, RG Maki, DM Araujo, J Trent, TF Williams, ... JAMA oncology 4 (12), e184060-e184060, 2018 | 170 | 2018 |
| Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery SC Katz, GR Point, M Cunetta, M Thorn, P Guha, NJ Espat, C Boutros, ... Cancer gene therapy 23 (5), 142-148, 2016 | 166 | 2016 |
| Eicosapentaenoic acid (EPA): an antiinflammatory ω-3 fat with potential clinical applications T Babcock, WS Helton, NJ Espat Nutrition 16 (11-12), 1116-1118, 2000 | 165 | 2000 |
| Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression … TA Babcock, T Novak, E Ong, DH Jho, WS Helton, NJ Espat Journal of Surgical Research 107 (1), 135-139, 2002 | 149 | 2002 |
| Soft tissue sarcoma brain metastases: prevalence in a cohort of 3829 patients NJ Espat, M Bilsky, JJ Lewis, D Leung, MF Brennan Cancer 94 (10), 2706-2711, 2002 | 146 | 2002 |
| Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. MA Rogy, T Auffenberg, NJ Espat, R Philip, D Remick, GK Wollenberg, ... The Journal of experimental medicine 181 (6), 2289-2293, 1995 | 145 | 1995 |
| Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response NJ Espat, T Auffenberg, JJ Rosenberg, M Rogy, D Martin, CH Fang, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 1996 | 137 | 1996 |
| Cytokine‐mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients NJ Espat, LL Moldawer, EM Copeland III Journal of surgical oncology 58 (2), 77-82, 1995 | 134 | 1995 |
| Gastrointestinal stromal tumors: a spectrum of disease C Sturgeon, G Chejfec, NJ Espat Surgical oncology 12 (1), 21-26, 2003 | 127 | 2003 |
| Tumour necrosis factor and cachexia: a current perspective NJ Espat, EM Copeland, LL Moldawer Surgical oncology 3 (5), 255-262, 1994 | 127 | 1994 |
| Total gastrectomy: options for the restoration of gastrointestinal continuity AC Chin, NJ Espat The lancet oncology 4 (5), 271-276, 2003 | 123 | 2003 |
